Literature DB >> 29095515

Increased odds of bladder and bowel symptoms in early Parkinson's disease.

Monica C Serra1,2, Alexus Landry3, Jorge L Juncos4, Alayne D Markland5,6, Kathryn L Burgio5,6, Patricia S Goode5,6, Theodore M Johnson1,2, Camille P Vaughan1,2.   

Abstract

AIMS: To compare the prevalence of urinary and bowel symptoms in a sample of adults with early Parkinson's disease (PD) and healthy controls (HC).
METHODS: Data were obtained from the Michael J. Fox Parkinson's Progression Markers Initiative (PPMI). Prevalent bladder (urinary incontinence (UI) and nighttime voiding) and bowel (constipation and fecal incontinence (FI)) symptoms were defined as occurring at least sometimes when queried using the Scale for Outcomes in PD for Autonomic Symptoms.
RESULTS: The proportion of men (65% vs 64%) and the mean age (61.0 ± 9.7 vs 60.2 ± 11.2 years) was similar between early PD (n = 423) and HC (n = 195). UI and constipation were more prevalent among early PD versus HC (UI: 26.7% vs 8.2%, constipation: 32.4% vs 11.8%; P's < 0.0001). Prevalent nighttime voiding was high among both groups, but not significantly different (82.5% vs 84.1%, P = 0.62). FI was infrequent in both. The odds of UI and constipation were significantly higher in early PD even after adjustment for age, sex, cognition, and overactive bladder (UI model only), constipation (UI and constipation models only), depression, and anxiety medication usage (UI: OR: 4.39 [95% CI: 2.92, 5.87]; constipation: 3.34 [2.20, 4.42]; P's < 0.0001).
CONCLUSIONS: While constipation is known to precede PD diagnosis, these data suggest that the occurrence of UI is elevated in early PD compared to a well-matched HC population.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Parkinson's disease; constipation; epidemiology; fecal incontinence; urinary incontinence

Mesh:

Year:  2017        PMID: 29095515      PMCID: PMC5924471          DOI: 10.1002/nau.23443

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  24 in total

1.  What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?

Authors:  David A Gallagher; Andrew J Lees; Anette Schrag
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

Review 2.  Bladder dysfunction in Parkinsonism: mechanisms, prevalence, symptoms, and management.

Authors:  Kristian Winge; Clare J Fowler
Journal:  Mov Disord       Date:  2006-06       Impact factor: 10.338

3.  Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases.

Authors:  Kathleen M Shannon; Ali Keshavarzian; Hemraj B Dodiya; Shriram Jakate; Jeffrey H Kordower
Journal:  Mov Disord       Date:  2012-05-01       Impact factor: 10.338

4.  Comparison of sleep and other non-motor symptoms between SWEDDs patients and de novo Parkinson's disease patients.

Authors:  Hui-Jun Yang; Young Eun Kim; Ji Young Yun; Gwanhee Ehm; Han-Joon Kim; Beom Seok Jeon
Journal:  Parkinsonism Relat Disord       Date:  2014-09-28       Impact factor: 4.891

5.  The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing.

Authors:  S Jackson; J Donovan; S Brookes; S Eckford; L Swithinbank; P Abrams
Journal:  Br J Urol       Date:  1996-06

6.  Prevalence of bladder dysfunction in Parkinsons disease.

Authors:  Kristian Winge; Anne-Marie Skau; Hans Stimpel; Kurt K Nielsen; Lene Werdelin
Journal:  Neurourol Urodyn       Date:  2006       Impact factor: 2.696

Review 7.  Gastrointestinal dysfunction in Parkinson's disease.

Authors:  Alfonso Fasano; Naomi P Visanji; Louis W C Liu; Antony E Lang; Ronald F Pfeiffer
Journal:  Lancet Neurol       Date:  2015-06       Impact factor: 44.182

8.  A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learned.

Authors: 
Journal:  Parkinsonism Relat Disord       Date:  2017-02-14       Impact factor: 4.891

Review 9.  The Parkinson Progression Marker Initiative (PPMI).

Authors: 
Journal:  Prog Neurobiol       Date:  2011-09-14       Impact factor: 10.885

10.  Priority setting partnership to identify the top 10 research priorities for the management of Parkinson's disease.

Authors:  Katherine H O Deane; Helen Flaherty; David J Daley; Roland Pascoe; Bridget Penhale; Carl E Clarke; Catherine Sackley; Stacey Storey
Journal:  BMJ Open       Date:  2014-12-14       Impact factor: 2.692

View more
  3 in total

1.  Urinary Dysfunction Is Associated with Nigrostriatal Dopaminergic Degeneration in Early and Untreated Patients with Parkinson's Disease.

Authors:  Jing Wang; Ruihua Cao; Tao Huang; Cheng Liu; Yidong Fan
Journal:  Parkinsons Dis       Date:  2020-11-28

2.  Executive Function Is Related to the Urinary Urgency in Non-demented Patients With Parkinson's Disease.

Authors:  Zuzanna Tkaczynska; Sara Becker; Walter Maetzler; Maarten Timmers; Luc Van Nueten; Patricia Sulzer; Giacomo Salvadore; Eva Schäffer; Kathrin Brockmann; Johannes Streffer; Daniela Berg; Inga Liepelt-Scarfone
Journal:  Front Aging Neurosci       Date:  2020-03-06       Impact factor: 5.750

3.  Constipation and sleep behaviour disorder associate with processing speed and attention in males with Parkinson's disease over five years follow-up.

Authors:  Wee Lee Kong; Yue Huang; Elizabeth Qian; Margaret J Morris
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.